The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: Insights from the first-in-man ABSORB Cohort B and SPIRIT II trials

Bill D. Gogas, Christos V. Bourantas, Hector M. Garcia-Garcia, Yoshinobu Onuma, Takashi Muramatsu, Vasim Farooq, Roberto Diletti, Robert Jan M. Van Geuns, Bernard De Bruyne, Bernard Chevalier, Leif Thuesen, Pieter C. Smits, Dariusz Dudek, Jacques Koolen, Stefan Windecker, Robert Whitbourn, Dougal McClean, Cecile Dorange, Karine Miquel-Hebert, Susan VeldhofRichard Rapoza, John A. Ormiston, Patrick W. Serruys

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Fingerprint Dive into the research topics of 'The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: Insights from the first-in-man ABSORB Cohort B and SPIRIT II trials'. Together they form a unique fingerprint.

Medicine & Life Sciences